Cargando…

An adaptive trial design for updating the threshold of a continuous biomarker

Detalles Bibliográficos
Autores principales:	Spencer, Amy, Harbron, Chris, Mander, Adrian, Wason, James, Peers, Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660074/ http://dx.doi.org/10.1186/1745-6215-16-S2-P228

Ejemplares similares

An adaptive design for updating the threshold value of a continuous biomarker
por: Spencer, Amy V., et al.
Publicado: (2016)

Stepped-wedge cluster randomised trials: where, when and why?
por: Grayling, Michael, et al.
Publicado: (2015)

A flexible method for determining a biomarker positive population based on an efficacy target within a confirmatory study
por: Harbron, Chris
Publicado: (2015)

A comparison of bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
por: Wason, James, et al.
Publicado: (2013)

An adaptive biomarker strategy clinical trial design
por: Wason, James, et al.
Publicado: (2013)

Adaptive enrichment in biomarker-stratified clinical trial design
por: Parashar, Deepak, et al.
Publicado: (2013)

Model selection and sample size adaptation: HYPAZ trial
por: Bond, Simon, et al.
Publicado: (2011)

Optimal multistage designs for randomised clinical trials with continuous outcomes
por: Wason, James MS, et al.
Publicado: (2012)

Incorporating historical control data into the design and analysis of clinical trials
por: Bennett, Maxine, et al.
Publicado: (2015)

Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
por: Lin, Chien-Ju, et al.
Publicado: (2015)

Simulation work in adaptive dose-finding designs to identify dose-intervals that achieve targets in multiple endpoints
por: Howlett, James, et al.
Publicado: (2015)

A Bayesian adaptive design for biomarker trials with linked treatments
por: Wason, James M S, et al.
Publicado: (2015)

Revisiting the multi-armed bandit model for the optimal design of clinical trials: benefits and drawbacks
por: Villar, Sofia S, et al.
Publicado: (2013)

Patient drift and response-adaptive randomisation: impact and solutions
por: Villar, Sofia S, et al.
Publicado: (2015)

A dynamical system analysis of the adaptive spike threshold
por: Platkiewicz, Jonathan, et al.
Publicado: (2007)

Minimizing the Maximum Expected Sample Size in Two-Stage Phase II Clinical Trials with Continuous Outcomes
por: Wason, James M. S., et al.
Publicado: (2012)

Use of an embedded, micro-randomised trial to investigate non-compliance in telehealth trials
por: Law, Lisa, et al.
Publicado: (2015)

The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected
por: Wason, James MS, et al.
Publicado: (2015)

Using an adaptive trial design for an infectious disease in primacy care - challenges in the design and set-up stages
por: Cook, Johanna, et al.
Publicado: (2015)

A toxicity-dependent feasibility bound for the escalation with overdose control approach in phase I cancer trials
por: Wheeler, Graham, et al.
Publicado: (2015)

The 3+3 versus model-based approach: implementation in the CAPCISUM pancreatic cancer trial
por: Qian, Wendi, et al.
Publicado: (2015)

How adaptation currents and synaptic inhibition change threshold, gain and variability of neuronal spiking
por: Ladenbauer, Josef, et al.
Publicado: (2013)

Stepped wedge cluster randomized controlled trial designs: a review of reporting quality and design features
por: Grayling, Michael J., et al.
Publicado: (2017)

Group sequential designs for stepped-wedge cluster randomised trials
por: Grayling, Michael J, et al.
Publicado: (2017)

Admissible multiarm stepped‐wedge cluster randomized trial designs
por: Grayling, Michael J., et al.
Publicado: (2018)

Phase II trial designs for complex interventions: a single-arm single-stage design for clustered continuous outcomes
por: Wilson, Duncan T, et al.
Publicado: (2015)

An optimised multi-arm multi-stage clinical trial design for unknown variance
por: Grayling, Michael J., et al.
Publicado: (2018)

Group sequential crossover trial designs with strong control of the familywise error rate
por: Grayling, Michael J., et al.
Publicado: (2018)

How Cancer Research UK is adapting to adaptive designs
por: Hearn, Julie, et al.
Publicado: (2011)

Choice of transformation for modelling non-linear continuous biomarkers
por: Stocken, Deborah D, et al.
Publicado: (2011)

Estimation bias in survival data within clinical trials that use adaptive seamless designs
por: Khan, Josephine, et al.
Publicado: (2015)

Adaptive designs for clinical trials assessing biomarker-guided treatment strategies
por: Wason, J, et al.
Publicado: (2014)

Update on the RESCUEicp decompressive craniectomy trial
por: Hutchinson, PJ, et al.
Publicado: (2011)

Adaptive dose-finding designs to identify multiple doses that achieve multiple response targets
por: Bond, Simon, et al.
Publicado: (2013)

Pain assessment: the relationship between pain thresholds and pain severity in osteoarthritis
por: Wylde, Vikki, et al.
Publicado: (2011)

Type I error control in biomarker-stratified clinical trials
por: Parashar, Deepak, et al.
Publicado: (2015)

Sample size requirements for pilot randomised controlled trials with continuous outcomes: a simulation study
por: Teare, Marion, et al.
Publicado: (2013)

Adaptive designs for phase II cross-over dose-finding trials using Bayesian model averaging
por: Simpson, Sarah, et al.
Publicado: (2015)

Optimal design for multi-arm multi-stage clinical trials
por: Wason, James MS, et al.
Publicado: (2011)

Practicalities of using an adaptive design for decision making within the optima trial: optimal personalized treatment of early breast cancer using multi-parameter tests
por: Dunn, Janet, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_s3j7mrd78sgsihpqclnrinft99